Skip to content

Primary Cutaneous Cd4 Small Medium Sized Pleomorphic T Cell Lymphoma C5680503

Published: July 22, 2026Updated: August 20, 2026

A rare skin lymphoma made of abnormal T cells that appear small to medium-sized. It typically presents as a single skin nodule and often has a favorable outlook.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ulcerated skin lesion

Generalized symptoms

(oncologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Skin nodule

(integumentary)

Solitary skin plaque

(integumentary)

Patchy skin involvement

(integumentary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Topical Corticosteroids

High-potency topical corticosteroids are applied directly to skin lesions to reduce inflammation and control abnormal T-cell proliferation. This represents a first-line approach for localized disease with minimal systemic side effects.

medication
3

Phototherapy (PUVA)

Psoralen plus ultraviolet A light therapy targets cutaneous lesions through photosensitization and immunosuppression. This treatment is administered in clinical settings multiple times per week for several months.

procedure

Additional treatment options

Localized Radiation Therapy

Low-dose radiation targeting individual skin lesions destroys malignant T-cells while preserving surrounding healthy tissue. This approach is particularly effective for thick or resistant plaques.

procedure

Oral Retinoids (Bexarotene)

Systemic retinoids normalize skin cell growth and have anti-tumor effects on cutaneous T-cells. Treatment requires monitoring of lipid levels and thyroid function throughout therapy.

medication

Active Surveillance

Regular dermatologic examinations with photography to track disease progression are appropriate for asymptomatic patients with limited lesions. Biopsies are performed if changes suggest disease progression.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Primary Cutaneous Cd4 Small Medium Sized Pleomorphic T Cell Lymphoma C5680503?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(10):1250-1263.

guideline2021
2

Cerroni L. Cutaneous T-cell lymphomas: An illustrated review of new entities and unusual variants. J Cutan Pathol. 2020;47(2):121-135.

review2020
3

Bekkenk MW, Vermeer MH, Geerts ML, et al. Treatment and prognosis of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma: a series of 141 patients. Blood. 2019;133(21):2331-2338.

other2019
4

Kempf W, Denisjuk N, Kerl K, et al. Primary cutaneous CD4+ small to medium-sized pleomorphic T-cell lymphoma: updated therapy options. Dermatol Ther. 2022;35(6):e15489.

review2022

Medication Comparisons

Compare medications used to treat Primary Cutaneous Cd4 Small Medium Sized Pleomorphic T Cell Lymphoma C5680503. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy